Vaxart (VXRT): Great Potential But Issues Remain | Seeking Alpha
Articles with Vaxart, Inc.
Webinar: The Quest for a COVID-19 Vaccine | The New York Academy of Sciences
COVID-19 Vaccines: Global Health Issues
Bioengineering | Free Full-Text | COVID-19 Vaccines: An Updated Overview of Different Platforms
Bioengineering | Free Full-Text | COVID-19 Vaccines: An Overview of Different Platforms
Frontiers | SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
Vaccines | Free Full-Text | Drop the Needle; A Temperature Stable Oral Tablet Vaccine Is Protective against Respiratory Viral Pathogens
COVID-19 vaccines: where we stand and challenges ahead | Cell Death & Differentiation
Vaxart stock rises as COVID pill vaccine shows response, safety in trial | Seeking Alpha
COVID-19 tracker: Omicron booster nods expected Wednesday
SARS-CoV-2 Vaccine Development: An Overview and Perspectives | ACS Pharmacology & Translational Science
Articles with Vaxart, Inc.
Prevention of host-to-host transmission by SARS-CoV-2 vaccines - The Lancet Infectious Diseases
Articles with Vaxart, Inc.
March 2020 – BioHealth Capital Region
avir20170630_10k.htm
avir20170630_10k.htm
Enabling Rapid Response and Sustained Capability with Medical Countermeasures to Mitigate Risk of Emerging Infectious Diseases:
avir20170630_10k.htm
Vaxart Has Developed the First Oral Investigational COVID-19 Vaccine
Vaxart appoints first general counsel | Corporate Secretary
